A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Estimation of serum homocysteine & lipid profile in chronic kidney disease patients
2022
International Journal of Health Sciences
Chronic kidney disease (CKD) is a deterioration of renal function, which results from diminished effective functioning of renal tissue. CKD is associated with dyslipidemia associating hypertriglyceridemia, elevated LDL cholesterol, an accumulation of apolipoprotein B (Apo B) containing lipoproteins, increased concentrations of lipoprotein(a) particles, and low HDL levels. Homocystein is considered as a risk or pathogenic factor in the progression of CKD which has been considered globally as a
doi:10.53730/ijhs.v6ns5.11136
fatcat:fj2wvbuo4nalbauhfjqxeqoxle